DoW, Ovarian Cancer, Investigator-Initiated Research Award
About
Summary: The Ovarian Cancer Research Program (OCRP) Investigator-Initiated Research Award is intended to support high-impact research that addresses a critical need and has the potential to make an important contribution to ovarian cancer or patient/survivor care. Distinctive Features: Application must contain strong research plan with sound scientific rational and logical reasoning. Preliminary data are required. Research projects may focus on any phase of research, from basic laboratory research through translational research, excluding clinical trials. Partnering Principal Investigator (PI) Option: The Partnering PI Option is structured so that two investigators, each of whom will be designated as a PI, will work synergistically on a single project. The results of this partnering project should significantly advance the research beyond what would be possible through individual efforts.
The DoW Ovarian Cancer Investigator-Initiated Research Award supports innovative, high-impact research addressing critical needs in ovarian cancer prevention, treatment, and patient care. This grant is designed for experienced research investigators and research teams committed to advancing the field through rigorous scientific inquiry. Funded projects may span the research continuum from basic laboratory science through translational research, excluding clinical trials. The program emphasizes research with strong scientific rationale, compelling preliminary data, and clear potential to significantly impact ovarian cancer outcomes or improve survivor quality of life. A distinctive Partnering PI Option allows two co-investigators to collaborate synergistically on a single project, enabling research scope that exceeds what individual researchers could accomplish. This award is ideal for investigators seeking to pursue novel research directions, validate preliminary findings, or explore emerging hypotheses in ovarian cancer science. By supporting investigator-driven research, this program accelerates discovery and innovation that can ultimately benefit patients and survivors.
Funding Facts
● Applications openDeadline
October 1, 2026
Who can apply
Last verified July 5, 2026 · Source: Grants.gov
Grant Details
Funding Range
Contact program for specific amounts
Deadline
2026-10-01
Grant Type
federal
Application Cycle
Annual with October 1, 2026 deadline
Best For
Research investigators pursuing novel ovarian cancer research in basic science and translational research
Frequently Asked Questions
Who is eligible for DoW, Ovarian Cancer, Investigator-Initiated Research Award?
Eligibility criteria are not specified in the available program information. Typically, such awards are available to research investigators at academic institutions, medical centers, and research organizations. Applicants should consult the official program website to confirm specific eligibility requirements, including institutional affiliation, investigator experience level, and other qualifying criteria.
How much funding does DoW, Ovarian Cancer, Investigator-Initiated Research Award provide?
Specific funding amounts are not provided in the available program details. Award amounts may vary based on project scope, research phase, and annual funding cycles. Contact the program directly or visit the official website for current funding ranges and budget guidelines.
How do I apply for DoW, Ovarian Cancer, Investigator-Initiated Research Award?
Applications must include a strong research plan with sound scientific rationale, logical reasoning, and preliminary data supporting the proposed research. The application process and submission requirements vary by funding cycle. Detailed instructions, forms, and submission deadlines are available on the official program website. Applicants should review these materials carefully before submitting.
What can DoW, Ovarian Cancer, Investigator-Initiated Research Award funding be used for?
Funding supports high-impact research addressing critical ovarian cancer needs, including basic laboratory research and translational research. Clinical trials are excluded from funding consideration. Research projects should have potential to make important contributions to ovarian cancer biology, treatment, prevention, or patient and survivor care outcomes.
Last updated: July 5, 2026